The Center for Advanced Molecular and Immunological Therapies will provide staff, facilities, support and services to advance precision medicine.

Phoenix will soon be the home of the Center for Advanced Molecular and Immunological Therapies, a new University of Arizona Health Sciences center focused on developing biological therapies that stimulate or suppress the immune system to fight disease.

Universities – and some providers themselves – are taking steps to close the gaps caused by a lack of nursing and medical education in hospice and palliative care.

Biological changes after fire exposure may increase firefighters’ disease risk, according to Mel and Enid Zuckerman College of Public Health researchers.

A study led by researchers at the University of Arizona Mel and Enid Zukerman College of Public Health identified changes in the cellular mechanisms controlling gene expression, called epigenetics, that may contribute to an increased risk of diseases including cancer in firefighters.

The worldwide incidence of cutaneous melanoma is predicted to rise sharply over the next two decades, according to a report from the International Agency for Research on Cancer. In an editorial, Mavis Obeng-Kusi, MPharm, and Ivo Abraham, PhD, RN, from the Center for Health Outcomes and PharmacoEconomic Research at the R. Ken Coit College of Pharmacy, said the findings are "sobering," but may substantially underestimate the gravity of the problem in low- and middle-income countries.

The World Health Organization is investigating hearing loss and ringing in the ears as potential rare side effects of the COVID-19 vaccines. The WHO's work is "overdue" but "helpful," according to Shaowen Bao, PhD, an assistant professor of physiology at the College of Medicine – Tucson, who is studying the COVID-19 vaccine and tinnitus.

Working in a combat hospital in the Middle East and trauma centers in rural America prepared Kristie Hoch to train future CRNAs to provide anesthesia care for patients.